Patients with BRCA and seven other forms of carcinoma under the age of 65 exhibited higher GTSE1 expression levels, whereas young patients with gastric adenocarcinoma had lower levels of GTSE1. This evidence concerns the gene GTSE1 and gastric adenocarcinoma.